Navigation Links
Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion
Date:11/8/2010

Table 45: Assessment of Takeda's cancer antihormonals portfolio, 2010 93

Table 46: Assessment of Novartis's cancer antihormonals portfolio, 2010 94

Table 47: Assessment of Pfizer's cancer antihormonals portfolio, 2010 94

Table 48: Assessment of Sanofi-Aventis's cancer antihormonals portfolio, 2010 95

Table 49: Regional launch dates for new antihormonals in the seven major markets, 2010-2019 103

Table 50: Patent expiry dates for the approved antihormonals in the seven major pharmaceutical markets, 2010-2019 103

List of Figures

Figure 26: Methodology for forecasting price to remove impact of currency fluctuations on future trend 105

To order this report:Therapy Industry: Commercial Insight: Antihormonal Cancer Therapies - Leading brands strive to minimize generic sales erosion

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Contact:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
2. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
3. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
4. High Unemployment Rates in North Carolina Will Continue to Dictate the Decrease of Commercial Health Plan Enrollment and the Increase of Medicaid Enrollment
5. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
6. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
7. Biocon and Pfizer Enter Into Global Commercialization Agreement
8. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
9. OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
10. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
11. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014  The Healthcare Analytics Summit 2014 ... Salt Lake City , Sept. 24-25 has ... healthcare organizations in the U.S. and beyond.  HAS ,14, ... conference devoted to providing immersive learning experiences on ... both accountable care initiatives and population health managemen ...
(Date:7/29/2014)... IRVING, Texas , July 29, 2014 /PRNewswire/ ... three new web-based applications with breakthrough interactive features ... and workflows for members of Children,s Hospital Association.  ... under the Novation Optimize Solutions umbrella – Value ... of how Novation helps organizations address the most ...
(Date:7/29/2014)... July 29, 2014   Abide Therapeutics ... to its board of directors. Thornberry was ... and Endocrinology for Merck & Co. Inc., where ... pipeline management in diabetes, osteoporosis, fertility and contraception. ... the program that resulted in the discovery of ...
Breaking Medicine Technology:Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
... Bayer HealthCare Pharmaceuticals was handed a pounding $100 ... unlikely to relieve.  The law firm of Sanford Wittels ... U.S. District Court for New Jersey, citing instances of ... employees at Novartis Pharmaceuticals who successfully won a jury ...
... 2011 Beginning April 1, Highmark Blue Cross Blue ... patients with primary immunodeficiency diseases and other rare disorders ... immunoglobulin (IgG - a blood plasma product), regardless of ... even patients who are being treated successfully with another ...
Cached Medicine Technology:Bayer Gets $100M Gender Class Action Headache 2Bayer Gets $100M Gender Class Action Headache 3Bayer Gets $100M Gender Class Action Headache 4Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 2Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 3
(Date:7/29/2014)... 2014 According to the new ... (Swipe And Area), Material (Optical Prism, Pizeoelectric, Capacitive, ... Commercial Security and Banking & Finance), and Geography ... 2020", published by MarketsandMarkets, the global Fingerprint Sensors ... 2020, growing at a high CAGR of 16.8% ...
(Date:7/29/2014)... best to treat patients after they,ve undergone surgery for ... comes back or provide men with additional radiation therapy ... from Thomas Jefferson University shows that a ... more informed decision. , "We are moving away from ... M.D., Assistant Professor of Radiation Oncology and Cancer Biology ...
(Date:7/29/2014)... repeatedly shown that death rates rise in association with ... in the summer of 2003, for example, resulted in ... by Dr. Alex-andra Schneider at the Institute of Epidemiology ... of extreme temperatures on the number of deaths caused ... both high and low temperatures in the study. , ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Foot Levelers ... lecturer at the Florida Chiropractic Association (FCA) National Convention ... Effects on the Kinetic Chain Changes on Thursday, August ... talk is focusing on the positive impact functional foot ... such as low back pain, plantar fasciitis, and hammertoes. ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Catalent ... solutions and advanced delivery technologies for pharmaceutical, biologic, ... Jeff Browne, R&D Director and US Platform Leader ... of Absorption-Limited Drugs with Lipid-Based Formulations using Soft ... Meeting of the Japan Society of Drug Delivery ...
Breaking Medicine News(10 mins):Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Genomic analysis of prostate cancer indicates best course of action after surgery 2Health News:Mortality rates increase due to extreme heat and cold 2Health News:Foot Levelers CEO Kent Greenawalt Speaking at FCA Convention 2Health News:Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems 2
... Mich., Nov. 19 Perrigo Company,(Nasdaq: PRGO ... by Sanofi-Aventis (NYSE: SNY ) against Barr ... BRL ). The suit was brought in,the ... filing of an ANDA,for Triamcinolone Acetonide Nasal Spray containing ...
... has Decreased By More than One-Fourth , ... federal government show that cigarette consumption in the U.S. has ... over the past decade, which marks a major milestone in ... of Attorneys General (NAAG) and the American Legacy Foundation (R) ...
... Mass., Nov. 19 Graeme Green Ph . ... discuss the results of the JUPITER study presented at the American ... , The results of the 17,802-patient trial demonstrated ... attack and death among patients who seemed healthy but showed high ...
... Appoints Paul Hamelin as President , ... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... BLA Oversight Committee ("the Committee")to oversee the regulatory and ... The Committee will be comprised of independent Board members ...
... PORT ORCHARD, Wash., Nov. 19 Stayhealthy, Inc. and ... program with the,Washington Fire Chief,s Fire Rescue Wellness Corporation ... firefighters. , "The ... top concern," said,Chief Wayne Senter, Fire Chief of South ...
... People in the middle of,separation or divorce often ... are shattered; the hope and joy that normally,accompany ... This year,s,economic downturn will add even more pressure ... already-difficult financial circumstances. , ...
Cached Medicine News:Health News:Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation 2Health News:Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation 3Health News:America Reaches Major Anti-Smoking Milestone 2Health News:America Reaches Major Anti-Smoking Milestone 3Health News:America Reaches Major Anti-Smoking Milestone 4Health News:America Reaches Major Anti-Smoking Milestone 5Health News:Analyst Available to Comment on New JUPITER Study That Shows AstraZeneca's Crestor Significantly Reduces CV Risk 2Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 2Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 3Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 4Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 5Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 6Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 7Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 8Health News:Washington Fire Firefighters Launch First of Its Kind Pilot Program on Health and Fitness 2Health News:Washington Fire Firefighters Launch First of Its Kind Pilot Program on Health and Fitness 3Health News:Holiday Season Amplifies Hurt of Separation and Divorce: Economic Woes Add to Pressure 2
... 2 gel holder cassettes, 4 fiber pads, ... buffer chamber, lid with cables, and instructions. ... of Bio-Rad's modular mini electrophoresis system (see ... of mini gels. Its modular electrode assembly ...
... 200 power supply. Flexibility ... Quantitative Transfers. Native Enzyme, ... Faster, Higher-Efficiency Transfers via ... Transfers with Movable Electrodes. ...
... gel holder cassettes, cell with ... pads, blot absorbent paper (15 ... transfer cell, used with the ... efficient, high-intensity electrophoretic transfers. The ...
... for running Criterion precast gels and ... blotter fit for use with the ... the Criterion blotter combines excellent blotting ... Trans-Blot system and the ease-of-use of ...
Medicine Products: